Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32754446)

Published in Front Oncol on July 10, 2020

Authors

Serena Di Cosimo1, Luca Porcu2, Andrea Malfettone3, Javier Cortés3,4,5,6,7, Rosalba Miceli8

Author Affiliations

1: Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
2: Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
3: Medica Scientia Innovation Research (MedSIR), New Jersey, United States.
4: Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
5: IOB Institute of Oncology, Quiron Group, Madrid, Spain.
6: IOB Institute of Oncology, Quiron Group, Barcelona, Spain.
7: Vall d'Hebron Insititute of Oncology (VHIO), Barcelona, Spain.
8: Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.